Bradley A Lloyd1, Clinton K Murray1, Faraz Shaikh2,3, M Leigh Carson2,3, Dana M Blyth1, Elizabeth R Schnaubelt4, Timothy J Whitman5, David R Tribble2. 1. San Antonio Military Medical Center, 3551 Roger Brooke Drive #3600, Fort Sam Houston, TX. 2. Infectious Disease Clinical Research Program, Preventive Medicine & Biostatistics Department Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD. 3. The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Suite 100, Bethesda, MD. 4. Landstuhl Regional Medical Center, Landstuhl, Germany. 5. Walter Reed National Military Medical Center, 8901 Wisconsin Avenue, Bethesda, MD.
Abstract
INTRODUCTION: All Department of Defense (DoD) guidance documents recommend cefazolin or clindamycin as post-trauma antibiotic prophylaxis for open soft-tissue injuries. Although not advocated, some patients with open soft-tissue injuries also received expanded Gram-negative coverage (EGN) prophylaxis based on the judgment of front-line trauma providers. During the study period, revised guidelines in 2011/2012 re-emphasized recommendations for using cefazolin or clindamycin, and stewardship efforts in the DoD trauma community aimed to reduce the practice of adding EGN to guideline-recommended antibiotic prophylaxis. Our objective was to examine antibiotic utilization among wounded military personnel with open extremity soft-tissue injuries over a 5-yr period and assess the impact on infectious outcomes in patients who received EGN prophylaxis versus guideline-directed prophylaxis. METHODS: The study population included military personnel with open extremity soft-tissue injuries sustained in Iraq and Afghanistan (2009-2014) who transferred to participating hospitals in the USA following medical evacuation. The analysis was restricted to patients who were hospitalized for at least seven days at a U.S. facility and excluded those who sustained open fractures. Post-trauma antibiotic prophylactic regimens were defined as narrow if they followed recommended guidance (e.g., IV cefazolin or clindamycin) or EGN coverage when the narrow regimen also included fluoroquinolones and/or aminoglycosides. Intravenous amoxicillin-clavulanate, which is commonly used at non-U.S. coalition theater hospitals, was also classified as narrow because it conformed to coalition antibiotic prophylaxis guidelines. This study was approved by the Infectious Disease Institutional Review Board of the Uniformed Services University of the Health Sciences. RESULTS: A total of 287 wounded personnel with open soft-tissue injuries were assessed, of which 212 (74%) received narrow prophylaxis and 75 (26%) received EGN coverage (p < 0.001). Among patients in the narrow prophylaxis group, 81% were given cefazolin and/or clindamycin, while 19% received amoxicillin-clavulanate. In the EGN group, 88% and 12% received a fluoroquinolone and aminoglycoside, respectively. Use of EGN coverage significantly declined during the study period from 39% in 2009-2010 to 11% in 2013-2014 (p < 0.001). Approximately 3% of patients who received a narrow regimen developed an extremity skin and soft-tissue infection, while there were no skin and soft-tissue infections among patients in the EGN coverage group. Nonetheless, this was not a significant difference (p = 0.345). In addition, the proportion of non-extremity infections was not significantly different between narrow and EGN regimen groups (11% and 15%, respectively). There were also no significant differences between the narrow and EGN regimen groups related to duration of hospitalization (median of 19 versus 20 d). CONCLUSION: Use of non-guideline directed EGN-based post-trauma antibiotic prophylaxis does not improve infectious outcomes nor does it shorten hospital stay. Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States 2018.
INTRODUCTION: All Department of Defense (DoD) guidance documents recommend cefazolin or clindamycin as post-trauma antibiotic prophylaxis for open soft-tissue injuries. Although not advocated, some patients with open soft-tissue injuries also received expanded Gram-negative coverage (EGN) prophylaxis based on the judgment of front-line trauma providers. During the study period, revised guidelines in 2011/2012 re-emphasized recommendations for using cefazolin or clindamycin, and stewardship efforts in the DoD trauma community aimed to reduce the practice of adding EGN to guideline-recommended antibiotic prophylaxis. Our objective was to examine antibiotic utilization among wounded military personnel with open extremity soft-tissue injuries over a 5-yr period and assess the impact on infectious outcomes in patients who received EGN prophylaxis versus guideline-directed prophylaxis. METHODS: The study population included military personnel with open extremity soft-tissue injuries sustained in Iraq and Afghanistan (2009-2014) who transferred to participating hospitals in the USA following medical evacuation. The analysis was restricted to patients who were hospitalized for at least seven days at a U.S. facility and excluded those who sustained open fractures. Post-trauma antibiotic prophylactic regimens were defined as narrow if they followed recommended guidance (e.g., IV cefazolin or clindamycin) or EGN coverage when the narrow regimen also included fluoroquinolones and/or aminoglycosides. Intravenous amoxicillin-clavulanate, which is commonly used at non-U.S. coalition theater hospitals, was also classified as narrow because it conformed to coalition antibiotic prophylaxis guidelines. This study was approved by the Infectious Disease Institutional Review Board of the Uniformed Services University of the Health Sciences. RESULTS: A total of 287 wounded personnel with open soft-tissue injuries were assessed, of which 212 (74%) received narrow prophylaxis and 75 (26%) received EGN coverage (p < 0.001). Among patients in the narrow prophylaxis group, 81% were given cefazolin and/or clindamycin, while 19% received amoxicillin-clavulanate. In the EGN group, 88% and 12% received a fluoroquinolone and aminoglycoside, respectively. Use of EGN coverage significantly declined during the study period from 39% in 2009-2010 to 11% in 2013-2014 (p < 0.001). Approximately 3% of patients who received a narrow regimen developed an extremity skin and soft-tissue infection, while there were no skin and soft-tissue infections among patients in the EGN coverage group. Nonetheless, this was not a significant difference (p = 0.345). In addition, the proportion of non-extremity infections was not significantly different between narrow and EGN regimen groups (11% and 15%, respectively). There were also no significant differences between the narrow and EGN regimen groups related to duration of hospitalization (median of 19 versus 20 d). CONCLUSION: Use of non-guideline directed EGN-based post-trauma antibiotic prophylaxis does not improve infectious outcomes nor does it shorten hospital stay. Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States 2018.
Entities:
Keywords:
antimicrobial prophylaxis; clinical practice guidelines; combat-related infections; extremity infections; open soft-tissue injuries
Authors: Duane R Hospenthal; Clinton K Murray; Romney C Andersen; Jeffrey P Blice; Jason H Calhoun; Leopoldo C Cancio; Kevin K Chung; Nicholas G Conger; Helen K Crouch; Laurie C D'Avignon; James R Dunne; James R Ficke; Robert G Hale; David K Hayes; Erwin F Hirsch; Joseph R Hsu; Donald H Jenkins; John J Keeling; R Russell Martin; Leon E Moores; Kyle Petersen; Jeffrey R Saffle; Joseph S Solomkin; Sybil A Tasker; Alex B Valadka; Andrew R Wiesen; Glenn W Wortmann; John B Holcomb Journal: J Trauma Date: 2008-03
Authors: Duane R Hospenthal; Clinton K Murray; Romney C Andersen; R Bryan Bell; Jason H Calhoun; Leopoldo C Cancio; John M Cho; Kevin K Chung; Jon C Clasper; Marcus H Colyer; Nicholas G Conger; George P Costanzo; Helen K Crouch; Thomas K Curry; Laurie C D'Avignon; Warren C Dorlac; James R Dunne; Brian J Eastridge; James R Ficke; Mark E Fleming; Michael A Forgione; Andrew D Green; Robert G Hale; David K Hayes; John B Holcomb; Joseph R Hsu; Kent E Kester; Gregory J Martin; Leon E Moores; William T Obremskey; Kyle Petersen; Evan M Renz; Jeffrey R Saffle; Joseph S Solomkin; Deena E Sutter; David R Tribble; Joseph C Wenke; Timothy J Whitman; Andrew R Wiesen; Glenn W Wortmann Journal: J Trauma Date: 2011-08
Authors: Bradley A Lloyd; Clinton K Murray; William Bradley; Faraz Shaikh; Deepak Aggarwal; M Leigh Carson; David R Tribble Journal: Mil Med Date: 2017-03 Impact factor: 1.437
Authors: David R Tribble; Nicholas G Conger; Susan Fraser; Todd D Gleeson; Ken Wilkins; Tanya Antonille; Amy Weintrob; Anuradha Ganesan; Lakisha J Gaskins; Ping Li; Greg Grandits; Michael L Landrum; Duane R Hospenthal; Eugene V Millar; Lorne H Blackbourne; James R Dunne; David Craft; Katrin Mende; Glenn W Wortmann; Rachel Herlihy; Jay McDonald; Clinton K Murray Journal: J Trauma Date: 2011-07
Authors: Bradley A Lloyd; Amy C Weintrob; Mary K Hinkle; Gerald R Fortuna; Clinton K Murray; William Bradley; Eugene V Millar; Faraz Shaikh; Kristen Vanderzant; Stacie Gregg; Gina Lloyd; Julie Stevens; M Leigh Carson; Deepak Aggarwal; David R Tribble Journal: Mil Med Date: 2014-03 Impact factor: 1.437
Authors: Laveta Stewart; Ping Li; Maj Dana M Blyth; Wesley R Campbell; Joseph L Petfield; Margot Krauss; Lauren Greenberg; David R Tribble Journal: Mil Med Date: 2020-01-07 Impact factor: 1.437
Authors: David R Tribble; Clinton K Murray; Bradley A Lloyd; Anuradha Ganesan; Katrin Mende; Dana M Blyth; Joseph L Petfield; Jay McDonald Journal: Mil Med Date: 2019-11-01 Impact factor: 1.437
Authors: Joseph L Petfield; Louis R Lewandowski; Laveta Stewart; Clinton K Murray; David R Tribble Journal: Mil Med Date: 2022-05-04 Impact factor: 1.563
Authors: David R Tribble; Mary Ann Spott; Stacey A Shackleford; Jennifer M Gurney; Bg Clinton K Murray Journal: Mil Med Date: 2022-05-04 Impact factor: 1.563